title: Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study.
abstract: There is an increasing recognition that, in the long term, total joint replacement may be associated with adverse local and remote tissue responses that are mediated by the degradation products of prosthetic materials. Particular interest has centered on the metal-degradation products of total joint replacements because of the known toxicities of the metal elements that make up the alloys used in the implants. We measured the concentrations of titanium, aluminum, cobalt, and chromium in the serum and the concentration of chromium in the urine of seventy-five patients during a three-year prospective, longitudinal study. Twenty patients had had a so-called hybrid total hip replacement (insertion of a modular cobalt-alloy femoral stem and head with cement and a titanium acetabular cup without cement), fifteen had had insertion of an extensively porous-coated cobalt-alloy stem with a cobalt-alloy head and a titanium-alloy socket without cement, and twenty had had insertion of a proximally porous-coated titanium-alloy stem with a cobalt-alloy head and a titanium socket without cement. The remaining twenty patients did not have an implant and served as controls. The results of our study showed that, thirty-six months postoperatively, patients who have a well functioning prosthesis with components containing titanium have as much as a threefold increase in the concentration of titanium in the serum and those who have a well functioning prosthesis with cobalt-alloy components have as much as a fivefold and an eightfold increase in the concentrations of chromium in the serum and urine, respectively. The predominant source of the disseminated chromium-degradation products is probably the modular head-neck junction and may be a function of the geometry of the coupling. Passive dissolution of extensively porous-coated cobalt-alloy stems was not found to be a dominant mode of metal release.
  
  
  CONCLUSIONS
  Increased concentrations of circulating metal-degradation products derived from orthopaedic implants may have deleterious biological effects over the long term that warrant investigation. This is a particularly timely concern because of recent clinical trends, including the reintroduction of metal-on-metal bearing surfaces and the increasing popularity of extensively porous-coated devices with large surface areas of exposed metal. Accurate monitoring of the concentrations of metal in the serum and urine after total hip replacement also can provide insights into the mechanisms of metal release. Our findings suggest that fretting corrosion at the head-neck coupling is an important source of metal release that can lead to increased concentrations of chromium in the serum. Determinations of the concentrations of metal in the serum and urine may be useful in the diagnosis of patients who are symptomatic after a total joint replacement as increased levels are indicative of at least one mode of mechanical dysfunction (for example, fretting corrosion) of the device.
authors.affiliation: Department of Orthopedic Surgery, Rush Arthritis and Orthopedics Institute, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA. jacobs@ortho4.pro.rpslmc.edu
authors.forename: J J
authors.initials: JJ
authors.lastname: Jacobs
authors.forename: A K
authors.initials: AK
authors.lastname: Skipor
authors.forename: L M
authors.initials: LM
authors.lastname: Patterson
authors.forename: N J
authors.initials: NJ
authors.lastname: Hallab
authors.forename: W G
authors.initials: WG
authors.lastname: Paprosky
authors.forename: J
authors.initials: J
authors.lastname: Black
authors.forename: J O
authors.initials: JO
authors.lastname: Galante
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000497:Alloys / Q000009:adverse effects / Q000737:chemistry*; D000535:Aluminum / Q000097:blood; D019644:Arthroplasty, Replacement, Hip; D001843:Bone Cements; D002857:Chromium / Q000097:blood / Q000652:urine; D020099:Coated Materials, Biocompatible / Q000737:chemistry; D003035:Cobalt / Q000097:blood; D003343:Corrosion; D005260:Female; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D016062:Porosity; D011446:Prospective Studies; D011474:Prosthesis Design; D012995:Solubility; D013499:Surface Properties; D014025:Titanium / Q000097:blood
chemical_list: D000497:Alloys; D001843:Bone Cements; D020099:Coated Materials, Biocompatible; D002857:Chromium; D003035:Cobalt; D000535:Aluminum; D014025:Titanium